Mesa Laboratories, Inc. MLAB
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 4.34M | 2.83M | -4.14M | 3.63M | 2.48M |
| Total Depreciation and Amortization | 5.56M | 5.65M | 5.75M | 5.72M | 5.85M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.26M | 3.34M | 8.42M | 4.93M | 5.35M |
| Change in Net Operating Assets | -10.07M | 2.93M | 3.93M | 4.48M | -5.45M |
| Cash from Operations | 4.10M | 14.74M | 13.96M | 18.75M | 8.22M |
| Capital Expenditure | -387.00K | -559.00K | -417.00K | -732.00K | -1.09M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -387.00K | -559.00K | -417.00K | -732.00K | -1.09M |
| Total Debt Issued | 0.00 | 10.00M | 0.00 | 0.00 | 97.00M |
| Total Debt Repaid | -11.41M | -18.66M | -14.69M | -8.69M | -103.44M |
| Issuance of Common Stock | 958.00K | -- | -- | -- | 1.06M |
| Repurchase of Common Stock | -- | -958.00K | -1.06M | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -898.00K | -884.00K | -884.00K | -884.00K | -882.00K |
| Other Financing Activities | -968.00K | -- | 873.00K | -214.00K | -1.63M |
| Cash from Financing | -12.31M | -10.50M | -15.76M | -9.79M | -7.88M |
| Foreign Exchange rate Adjustments | 222.00K | 88.00K | 167.00K | 316.00K | -104.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.38M | 3.77M | -2.05M | 8.55M | -857.00K |